(Q41936517)

English

Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice

scientific article published on December 1993

Statements

Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice (English)
1 December 1993
3599-3606

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit